Clinical Trial Update: NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial update evaluates natural killer (NK) cell therapy in combination with interleukin for children and young adults with advanced solid tumors, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Neuroblastoma
• Sarcoma
• Solid Tumors

Drugs mentioned

• Interleukin (interleukin)
• Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Brain Tumors | Phase 1 | Status: COMPLETED